CELLINK has entered into an agreement to acquire the advanced robotics and diagnostics automation company Ginolis CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders of Ginolis Oy ("Ginolis"), a Finnish company focusing on diagnostics automation and advanced [...] 02/15/2021 | Company news
CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery CELLINK scientists will continue to work side-by-side in AstraZeneca labs, aiming to accelerate discovery of new disease targets and therapeutics. CELLINK, a bioconvergence company focused […] 01/28/2021 | Company news
CELLINK launches UP.SIGHT, a rapid, all-in-one imager and single-cell dispenser that offers double assurance of clonality UP.SIGHT™ is certified to help laboratories worldwide overcome major cell line development hurdles and improve efficiency across workflows. cytena GmbH, a CELLINK company and leader […] 01/28/2021 | Company news
CELLINK to bring Livecyte high content live cell imager to a wider audience Today, CELLINK and Phasefocus announced a partnership to bring Livecyte, a high content live cell imager, to a wider market. Live cell imaging is essential [...] 01/19/2021 | Company news
CELLINK will help develop 3D bioprinted personalised scaffolds for tissue regeneration of ankle joint s as part of the TRIANKLE project The TRIANKLE consortium – made up of 12 European organisations, will develop 3D bioprinted personalised scaffolds for tissue regeneration of ankle joints. This ambitious research […] 11/11/2020 | Company news
CELLINK launches CASY CELLINK Life Sciences has partnered with Omni Life Science to make the CASY Cell Counter and Analyzer available to a wider market. CASY tracks the […] 10/22/2020 | Company news
CELLINK launches C.WASH Today, CELLINK launches the C.WASH, an innovative liquid handling system for media change in cellular assays and tipless magnetic bead washing. Among other workflows, the […] 10/22/2020 | Company news
Q4 19/20: Strong organic growth and important strategic acquisition under continued challenging conditions CELLINK publishes the interim report for the period June 2020 – August 2020 as well as the report for the first 12 months. The report […] 10/22/2020 | Company news
CELLINK’s Electromagnetic Droplet (EMD) Printhead leverages inkjet technology to enable users to print at high speeds with precision. With integrated heat control, the EMD Printhead […] Printing cells with the Electromagnetic Droplet Printhead CELLINK’s Electromagnetic Droplet (EMD) Printhead leverages inkjet technology to enable users to print at high speeds with precision. With integrated heat control, the EMD Printhead […] 09/09/2020 | Uncategorized
CELLINK has entered into an agreement to acquire precision dispensing company Scienion Ag WED, AUG 19, 2020 17:30 CET CELLINK AB (publ) (“CELLINK”) has entered into an agreement with the owners of Scienion Ag (“Scienion”), a German life science […] 08/19/2020 | Company news
Partnership with Carcinotech to advance 3D-bioprinting technology for cancer research CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research 08/14/2020 | Company news
Engineering a 3D human myocardial tissue model INTRODUCTION Casper van der Ven and Nino Chirico are PhD students in the Regenerative Medicine Programme at Utrecht University, the Netherlands. They research cardiac tissue […] 08/09/2020 | 3d bioprinting